Danaher Corporation Stock

Equities

DHR

US2358511028

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-05-01 pm EDT 5-day change 1st Jan Change
246.9 USD +0.11% Intraday chart for Danaher Corporation -1.41% +6.72%
Sales 2024 * 23.9B Sales 2025 * 26B Capitalization 183B
Net income 2024 * 4.44B Net income 2025 * 5.39B EV / Sales 2024 * 8 x
Net Debt 2024 * 8.58B Net Debt 2025 * 1.58B EV / Sales 2025 * 7.09 x
P/E ratio 2024 *
41.6 x
P/E ratio 2025 *
33.9 x
Employees 62,000
Yield 2024 *
0.44%
Yield 2025 *
0.47%
Free-Float 74.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.11%
1 week-2.46%
Current month+0.11%
1 month-1.13%
3 months+2.91%
6 months+28.58%
Current year+6.72%
More quotes
1 week
243.68
Extreme 243.68
250.64
1 month
230.74
Extreme 230.74
256.72
Current year
222.53
Extreme 222.53
259.00
1 year
182.09
Extreme 182.09
269.61
3 years
182.09
Extreme 182.09
333.96
5 years
119.60
Extreme 119.6
333.96
10 years
70.12
Extreme 70.12
333.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 09-12-31
Founder 72 82-12-31
Founder 67 82-12-31
Members of the board TitleAgeSince
Founder 67 82-12-31
Director/Board Member 72 99-06-30
Founder 72 82-12-31
More insiders
Date Price Change Volume
24-05-01 246.9 +0.11% 2,292,363
24-04-30 246.6 -0.08% 3,940,994
24-04-29 246.8 +0.10% 1,616,439
24-04-26 246.6 +0.32% 2,710,446
24-04-25 245.8 -1.84% 2,943,566

Delayed Quote Nyse, May 01, 2024 at 04:00 pm EDT

More quotes
Danaher Corporation is an industrial and technologic group organized around two families of products: - medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.; - professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc. Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
246.9 USD
Average target price
269.9 USD
Spread / Average Target
+9.31%
Consensus